Received Dec 28, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RSV | RSV (AREXVY) | GLAXOSMITHKLINE BIOLOGICALS | N/A | YE232 | IM / LA |
PATIENT RECEIVED RSV VACCINE (AREXVY) ON 11/26/25. CURRENT GUIDELINES ONLY RECOMMENDS ONE DOES OF RSV VACCINATION, BUT PATIENT HAD RECEIVED ANOTHER RSV (ABRYSVO) DOSE ON 3/9/25. DURING VACCINE ELGIBILITY CHECK ON 11/26/25, REGISTRY REPORT SHOWED THAT PATIENT DID NOT HAVE AN RSV VACCINE IN THE PAST. THERE WAS AN ERROR IN REGISTRY REPORT THAT WAS PULLED ON 11/26/25. PATIENT WAS CONSULTED ON 12/17/25 AFTER DISCOVERY OF THE ADDITIONAL DOSE OF RSV. PATIENT STATED THERE WERE NO ADVERSE EFFECT FROM THE VACCINATION FROM 11/26/25.